Expression of FLIP in human colon carcinomas: A new mechanism of immune evasion
β Scribed by Bao-cai Xing; S. Wimmenauer; EH. Farthmann
- Book ID
- 107466764
- Publisher
- Chinese Anti-Cancer Association
- Year
- 2005
- Tongue
- English
- Weight
- 587 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1000-9604
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Fas ligand (FasL) kills sensitive Fas receptor (FasR)-bearing cells by inducing apoptosis. FasL expressed by non-lymphoid cells within the eye and the testis mediates immune privilege by inducing apoptosis of Fas-sensitive infiltrating pro-inflammatory immune effector cells. It has previously been d
The production in colon cancer of interferon-gamma (IFN-β₯), a type-1 T-helper (TH1) cytokine, is considered as a marker of good prognosis. We asked whether interleukin-18 (IL-18), which strongly induces IFN-β₯ and regulates Fas ligand (Fas-L)-dependent cytotoxicity, may play a role in colon homeostas
FLICE-like inhibitory protein (FLIP), a naturally occurring caspase-inhibitory protein that lacks the critical cysteine domain necessary for catalytic activity, is a negative regulator of Fas-induced apoptosis. Decreased FLIP levels sensitize tumor cells to Fas-and TRAIL-mediated apoptosis; however,